Concepedia

William S. Velasquez

WS

43

Publications

4.2K

Citations

30

H-Index

1981

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Lymphoma Research Foundation

Anderson Hospital

Texas Medical Center

The University of Texas System

William S. Velasquez is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1981–2003

43

Publications

43

Fludarabine: a new agent with major activity against chronic lymphocytic leukemia

MJ Keating, H. Kantarjian, Moshe Talpaz et al. · Blood · 1989 · 455 citations · Full text

ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study.

William S. Velasquez, Peter McLaughlin, Fredrick B. Hagemeister et al. · Journal of Clinical Oncology · 1994 · 427 citations

Single-Agent Monoclonal Antibody Efficacy in Bulky Non-Hodgkin's Lymphoma: Results of a Phase II Trial of Rituximab

Thomas A. Davis, Christine A. White, A.J. Grillo-López et al. · Journal of Clinical Oncology · 1999 · 289 citations

, , +16

Fludarabine: a new agent with major activity against chronic lymphocytic leukemia

MJ Keating, Hagop M. Kantarjian, Moshe Talpaz et al. · Blood · 1989 · 262 citations · Full text

Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy.

Miguel F Cunha, Marvin L. Meistrich, Lillian M. Fuller et al. · Journal of Clinical Oncology · 1984 · 238 citations

, , +20

Rows per page

1–5 of 43